HomeNDC LookupRxCUI directory › RxCUI 198142

Prednisolone 5 MG Oral Tablet — RxCUI 198142

RxNorm drug concept · Semantic clinical drug
RxCUI 198142 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 6 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI198142
Official namePrednisolone 5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped4
Package NDCs mapped6
Reported Medicaid activity (SDUD)2,137 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Prednisolone: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Prednisolone is a steroid that calms inflammation and dials down an overactive immune system. Depending on what you're being treated for — whether that's an asthma flare, a skin co...
  • Why has my doctor prescribed prednisolone — what is it actually doing?
  • Please don't stop on your own — this is one of the most important things to know about prednisolone. When you take it for more than a short time, your adrenal glands slow down thei...
  • Can I stop taking prednisolone when I start feeling better?
📖 Read our full Prednisolone guide →

🕸️ Concept Web — How Prednisolone 5 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Prednisolone 5 MG Oral Tablet RxCUI 198142

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Prednisolone 8638
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • MILLIPRED 795094
    • Prednistab 1191678
  3. Dose forms 12

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Prednisolone Oral Tablet 373578
    • Prednisolone Oral Product 1165759
    • Prednisolone Pill 1156758
    • Prednisolone Oral Tablet [MILLIPRED] 808117
    • Prednisolone Oral Tablet [Prednistab] 1191680
    • MILLIPRED Oral Product 1184934
    • MILLIPRED Pill 1184935
    • Prednistab Oral Product 1191681
    • +4 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Prednisolone 5 MG 316579
    • Prednisolone 5 MG Oral Tablet [MILLIPRED] 808118
    • Prednisolone 5 MG Oral Tablet [Prednistab] 1191686
    • Prednisolone 5 MG [MILLIPRED] 808116
    • Prednisolone 5 MG [Prednistab] 1191685
  5. Packs 4

    Fixed collections of drugs packaged and sold together, like dose packs.

    • {21 (prednisolone 5 MG Oral Tablet [MILLIPRED]) } Pack [Millipred DP 6 Day] 1235042
    • {48 (prednisolone 5 MG Oral Tablet [MILLIPRED]) } Pack [Millipred DP 12 Day] 1005831
    • {21 (prednisolone 5 MG Oral Tablet) } Pack 1013114
    • {48 (prednisolone 5 MG Oral Tablet) } Pack 1005830

Showing up to 8 concepts per family — 20 of 24 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Prednisolone 5 MG SCDC · 316579
  • Prednisolone Oral Tablet SCDF · 373578
  • Prednisolone Oral Product SCDG · 1165759
  • Prednisolone Pill SCDG · 1156758
  • {21 (prednisolone 5 MG Oral Tablet) } Pack GPCK · 1013114
  • {48 (prednisolone 5 MG Oral Tablet) } Pack GPCK · 1005830

Brand-Name Concepts

  • Prednisolone 5 MG Oral Tablet [MILLIPRED] SBD · 808118
  • Prednisolone 5 MG Oral Tablet [Prednistab] SBD · 1191686
  • Prednisolone 5 MG [MILLIPRED] SBDC · 808116
  • Prednisolone 5 MG [Prednistab] SBDC · 1191685
  • Prednisolone Oral Tablet [MILLIPRED] SBDF · 808117
  • Prednisolone Oral Tablet [Prednistab] SBDF · 1191680
  • MILLIPRED Oral Product SBDG · 1184934
  • MILLIPRED Pill SBDG · 1184935
  • Prednistab Oral Product SBDG · 1191681
  • Prednistab Pill SBDG · 1191682

📦 FDA Products & Package NDCs

4 products · 6 package NDCs
6 package NDCs map to RxCUI 198142 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42658-0160-05 100 TABLET in 1 BOTTLE (42658-160-05) PREDNISOLONE Hisun Pharmaceuticals USA, Inc. 2024-09-01
59651-0491-01 100 TABLET in 1 BOTTLE (59651-491-01) PREDNISOLONE Aurobindo Pharma Limited 2023-03-17
59651-0491-50 50 TABLET in 1 BOTTLE (59651-491-50) PREDNISOLONE Aurobindo Pharma Limited 2023-03-17
60722-5011-00 100 TABLET in 1 BOTTLE (60722-5011-0) PREDNISOLONE Zhejiang Xianju Pharmaceutical Co., Ltd. 2024-09-01
60722-5011-01 1000 TABLET in 1 BOTTLE (60722-5011-1) PREDNISOLONE Zhejiang Xianju Pharmaceutical Co., Ltd. 2024-09-01
62135-0437-30 30 TABLET in 1 BOTTLE (62135-437-30) Prednisolone Chartwell RX, LLC 2023-03-08
Observed labelers: Aurobindo Pharma Limited (2) · Zhejiang Xianju Pharmaceutical Co., Ltd. (2) · Chartwell RX, LLC (1) · Hisun Pharmaceuticals USA, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$8.5057
Range $8.5057–$8.5057 · middle 50% $8.5057–$8.5057 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7510 Prednisolone oral per 5 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.